bisoprolol has been researched along with Ventricular Dysfunction, Left in 37 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with depressed < or =35% ejection fraction after acute myocardial infarction treatment with low doses of metoprolol, bisoprolol and cardvediolol did not reduce mortality rate in 24-month observation." | 9.12 | [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction]. ( Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J, 2006) |
| "The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats." | 7.96 | Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats. ( Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A, 2020) |
| "The objective of this study was to establish the benefit of bisoprolol up-titration toward recommended dosage targets, versus lower-dose maintenance, in heart failure (HF) patients with systolic dysfunction." | 7.83 | Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction. ( Cha, TJ; Choi, DJ; Choi, SW; Han, SW; Hwang, KK; Jeon, H; Kim, HJ; Kim, JH; Kim, SH; Kim, YJ; Ryu, KH; Shim, WJ; Shin, MS; Yoo, BS, 2016) |
| "to evaluate of the effectiveness of switching from beta-adrenoblockers (BAB) non-included into the guidelines for the management of chronic heart failure (CHF) to nebivolol and bisoprolol for outpatients." | 5.14 | [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting]. ( Ageev, FT; Blankova, ZN; Kheĭmets, GI; Kuz'mina, AE; Ovchinnikov, AG; Patrusheva, IF; Seredenina, EM; Zhubrina, ES, 2009) |
| "In patients with depressed < or =35% ejection fraction after acute myocardial infarction treatment with low doses of metoprolol, bisoprolol and cardvediolol did not reduce mortality rate in 24-month observation." | 5.12 | [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction]. ( Chizyński, K; Goch, JH; Maciejewski, M; Ptaszyński, P; Ruta, J, 2006) |
| " Studies investigating any of three beta blockers (carvedilol, bisoprolol, and extended release metoprolol succinate) which are known to be effective in adult patients with heart failure were included." | 4.91 | Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies. ( Cho, MJ; Jung Kwak, M; Kim, HY; Kim, YM; Lee, HD; Lim, RK; Park, KH, 2015) |
| "The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats." | 3.96 | Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats. ( Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A, 2020) |
| "The objective of this study was to establish the benefit of bisoprolol up-titration toward recommended dosage targets, versus lower-dose maintenance, in heart failure (HF) patients with systolic dysfunction." | 3.83 | Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction. ( Cha, TJ; Choi, DJ; Choi, SW; Han, SW; Hwang, KK; Jeon, H; Kim, HJ; Kim, JH; Kim, SH; Kim, YJ; Ryu, KH; Shim, WJ; Shin, MS; Yoo, BS, 2016) |
| "Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4." | 3.72 | [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004) |
| "To determine tolerability and symptom changes associated with the introduction of bisoprolol treatment in older patients with heart failure." | 3.71 | Beta blockers in older persons with heart failure: tolerability and impact on quality of life. ( Baxter, AJ; Gray, CS; Hildreth, A; Karimova, G; O'Connell, JE; Spensley, A, 2002) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "β-blockers are an important treatment of heart failure (HF) and are useful in reducing the progression of the syndrome." | 2.48 | β-blockers in stage B: a precursor of heart failure. ( Francis, GS; Sarraf, M, 2012) |
| " We analyze the problems with the trial design of COMET from the standpoint of comparing 2 therapeutic agents at different positions on a common dose-response curve, and discuss the theoretical reasons why postjunctional adrenergic receptor blockade that is in addition to beta1-receptor antagonism will likely produce only minimal or no incremental benefit in chronic heart failure." | 2.42 | Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? ( Adams, KF; Bristow, MR; Feldman, AM; Goldstein, S, 2003) |
| " To date, controlled clinical trials performed in more than 13,000 patients with chronic heart failure have consistently shown that the long term administration of beta-blockers is associated with significant improvement in left ventricular function, clinical symptoms, and survival." | 2.41 | [Role of beta-blockers in the treatment of chronic heart heart failure]. ( Czuriga, I; Edes, I, 2001) |
| "It remains unclear whether dilated cardiomyopathy (DCM) is a primary feature of ATS." | 1.43 | Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome. ( Duff, HJ; Ferrier, RA; Gerull, B; Guo, J; Rezazadeh, S, 2016) |
| "A metoprolol therapy was established, however to resistant tachycardia, we suggested a combined therapy of Bisoprolol and Ivabradin, which resulted successfully in normocard sinus rhythm." | 1.40 | [A heart without overspeed trip unit]. ( Gähwiler, R; Ghadri, JR; Lüscher, TF; Templin, C, 2014) |
| " After a slow increase in the dosage to 10 mg enalapril/day and 2." | 1.36 | Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T. ( Finsterer, J; Holinski-Feder, E; Stöllberger, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 19 (51.35) | 29.6817 |
| 2010's | 11 (29.73) | 24.3611 |
| 2020's | 4 (10.81) | 2.80 |
| Authors | Studies |
|---|---|
| Yokota, T | 1 |
| Koiwa, H | 1 |
| Matsushima, S | 1 |
| Tsujinaga, S | 1 |
| Naya, M | 1 |
| Morisaki, H | 1 |
| Morisaki, T | 1 |
| Sharma, K | 1 |
| Desai, H | 1 |
| Sharm, N | 1 |
| Laddha, M | 1 |
| Hansora, K | 1 |
| Vazirani, P | 1 |
| Watanabe, T | 1 |
| Imai, Y | 1 |
| Morita, E | 1 |
| Okuyama, T | 1 |
| Watanabe, H | 1 |
| Yokota, A | 1 |
| Komori, T | 1 |
| Kabutoya, T | 1 |
| Shimpo, M | 1 |
| Hachiya, H | 1 |
| Kario, K | 1 |
| Krasnova, M | 1 |
| Kulikov, A | 1 |
| Okovityi, S | 1 |
| Ivkin, D | 1 |
| Karpov, A | 1 |
| Kaschina, E | 2 |
| Smirnov, A | 1 |
| Springer, J | 1 |
| Tschirner, A | 1 |
| Haghikia, A | 1 |
| von Haehling, S | 1 |
| Lal, H | 1 |
| Grzesiak, A | 1 |
| Palus, S | 1 |
| Pötsch, M | 1 |
| von Websky, K | 1 |
| Hocher, B | 1 |
| Latouche, C | 1 |
| Jaisser, F | 1 |
| Morawietz, L | 1 |
| Coats, AJ | 1 |
| Beadle, J | 1 |
| Argiles, JM | 1 |
| Thum, T | 1 |
| Földes, G | 1 |
| Doehner, W | 1 |
| Hilfiker-Kleiner, D | 1 |
| Force, T | 1 |
| Anker, SD | 1 |
| Gähwiler, R | 1 |
| Templin, C | 1 |
| Lüscher, TF | 1 |
| Ghadri, JR | 1 |
| Tanaka, H | 1 |
| Matsumoto, K | 1 |
| Sawa, T | 1 |
| Miyoshi, T | 1 |
| Motoji, Y | 1 |
| Imanishi, J | 1 |
| Mochizuki, Y | 1 |
| Tatsumi, K | 1 |
| Hirata, K | 1 |
| Cho, MJ | 1 |
| Lim, RK | 1 |
| Jung Kwak, M | 1 |
| Park, KH | 1 |
| Kim, HY | 1 |
| Kim, YM | 1 |
| Lee, HD | 1 |
| Han, SW | 1 |
| Choi, SW | 1 |
| Ryu, KH | 1 |
| Kim, HJ | 1 |
| Kim, SH | 1 |
| Shim, WJ | 1 |
| Cha, TJ | 1 |
| Choi, DJ | 1 |
| Kim, YJ | 1 |
| Yoo, BS | 1 |
| Kim, JH | 1 |
| Hwang, KK | 1 |
| Jeon, H | 1 |
| Shin, MS | 1 |
| Rezazadeh, S | 1 |
| Guo, J | 1 |
| Duff, HJ | 1 |
| Ferrier, RA | 1 |
| Gerull, B | 1 |
| Das, M | 1 |
| Allen LaPointe, NM | 1 |
| Zhou, Y | 1 |
| Stafford, JA | 1 |
| Hernandez, AF | 1 |
| Kramer, JM | 1 |
| Anstrom, KJ | 1 |
| Adams, KF | 2 |
| Duncker, DJ | 1 |
| Boontje, NM | 1 |
| Merkus, D | 1 |
| Versteilen, A | 1 |
| Krysiak, J | 1 |
| Mearini, G | 1 |
| El-Armouche, A | 1 |
| de Beer, VJ | 1 |
| Lamers, JM | 1 |
| Carrier, L | 1 |
| Walker, LA | 1 |
| Linke, WA | 1 |
| Stienen, GJ | 1 |
| van der Velden, J | 1 |
| Zhubrina, ES | 1 |
| Ovchinnikov, AG | 1 |
| Seredenina, EM | 1 |
| Patrusheva, IF | 1 |
| Blankova, ZN | 1 |
| Kuz'mina, AE | 1 |
| Kheĭmets, GI | 1 |
| Ageev, FT | 1 |
| Remme, WJ | 1 |
| Finsterer, J | 1 |
| Stöllberger, C | 1 |
| Holinski-Feder, E | 1 |
| Sarraf, M | 1 |
| Francis, GS | 1 |
| Patel, H | 1 |
| Dhillon, G | 1 |
| Bandali, A | 1 |
| Patel, N | 1 |
| Baxter, AJ | 1 |
| Spensley, A | 1 |
| Hildreth, A | 1 |
| Karimova, G | 1 |
| O'Connell, JE | 1 |
| Gray, CS | 1 |
| Podbregar, M | 1 |
| Voga, G | 1 |
| Bristow, MR | 1 |
| Feldman, AM | 1 |
| Goldstein, S | 1 |
| Fukuchi, K | 1 |
| Yasumura, Y | 1 |
| Kiso, K | 1 |
| Hayashida, K | 1 |
| Miyatake, K | 1 |
| Ishida, Y | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Kanopskiĭ, SG | 1 |
| Staritskiĭ, AG | 1 |
| Bozhko, AA | 1 |
| Schlosser, T | 1 |
| Mohrs, OK | 1 |
| Magedanz, A | 1 |
| Voigtländer, T | 1 |
| Schmermund, A | 1 |
| Barkhausen, J | 1 |
| Ruta, J | 1 |
| Ptaszyński, P | 1 |
| Maciejewski, M | 1 |
| Goch, JH | 1 |
| Chizyński, K | 1 |
| Ennezat, PV | 1 |
| Gonin, X | 1 |
| Darchis, J | 1 |
| De Groote, P | 1 |
| Lamblin, N | 1 |
| Bauters, C | 1 |
| Lejemtel, T | 1 |
| Asseman, P | 1 |
| Erne, P | 1 |
| Schoenenberger, AW | 1 |
| Zuber, M | 1 |
| Burckhardt, D | 1 |
| Kiowski, W | 1 |
| Dubach, P | 1 |
| Resink, T | 1 |
| Pfisterer, M | 1 |
| Hamaad, A | 1 |
| Lip, GY | 1 |
| Nicholls, D | 1 |
| MacFadyen, RJ | 1 |
| Strauer, BE | 1 |
| Schwartzkopff, B | 1 |
| Segev, A | 1 |
| Mekori, YA | 1 |
| McMurray, JJ | 1 |
| Frantz, RP | 1 |
| Coutinho, J | 1 |
| Czuriga, I | 1 |
| Edes, I | 1 |
8 reviews available for bisoprolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Topics: Adrenergic beta-Antagonists; Age Factors; Bisoprolol; Carbazoles; Carvedilol; Child; Heart Defects, | 2015 |
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindi | 2002 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; C | 2012 |
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; E | 2003 |
Major beta blocker mortality trials in chronic heart failure: a critical review.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bisoprolol; Carbazoles; Carvedilol; Female; He | 1999 |
Beta blockade in patients with congestive heart failure. Why, who, and how.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; H | 2000 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; | 2001 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinica | 2001 |
7 trials available for bisoprolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
[Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Benzopyrans; Bisoprolol; Chronic Disease; Ethano | 2009 |
Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Aged; Basal Metabolism; Bisoprolol; Blood Pressure; Bod | 2002 |
Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Bisoprolol; Carbazoles; Cardiomyopathy, Dilat | 2004 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
[Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon, Coronary; Bisoprolol; | 2006 |
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Bisoprolol; Death, Su | 2007 |
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Chroni | 2007 |
22 other studies available for bisoprolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Loeys-Dietz Cardiomyopathy? Long-term Follow-up After Onset of Acute Decompensated Heart Failure.
Topics: Acute Disease; Bisoprolol; Cardiomegaly; Cardiomyopathies; Cardiovascular Agents; Echocardiography; | 2022 |
To Evaluate the 'Real World' Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.
Topics: Bisoprolol; Female; Glycated Hemoglobin; Heart Failure; Humans; Lipids; Male; Middle Aged; Myocardia | 2022 |
Time Course of Left Ventricular Pseudoaneurysm After Catheter Ablation of LVOT Tachycardia.
Topics: Aneurysm, False; Bisoprolol; Cardiovascular Agents; Catheter Ablation; Female; Heart Ventricles; Hum | 2020 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, A | 2020 |
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolo | 2014 |
[A heart without overspeed trip unit].
Topics: Adult; Algorithms; Benzazepines; Bisoprolol; Diagnosis, Differential; Drug Therapy, Combination; Ech | 2014 |
Evaluation of global circumferential strain as prognostic marker after administration of β-blockers for dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Area Under Curve; Bisoprolol; Carbazoles; Cardiomyopathy, | 2014 |
Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Biomarkers; Bisoprolol; Blood Pressure; Drug Administr | 2016 |
Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Andersen Syndrome; Bisoprolol; Cardiomyopathy, Dilate | 2016 |
Small benefits in trastuzumab-related cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Age | 2017 |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carb | 2009 |
Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Topics: Actin Cytoskeleton; Adrenergic beta-Antagonists; Animals; Bisoprolol; Calcium Signaling; Cardiac Myo | 2009 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Tria | 2010 |
Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Drug Therapy, Combination; Enalapril; Humans; Male; Musc | 2010 |
A young patient with heart failure: picture quiz question.
Topics: Adult; Bisoprolol; Blood Chemical Analysis; Drug Therapy, Combination; Echocardiography, Doppler; El | 2012 |
Beta blockers in older persons with heart failure: tolerability and impact on quality of life.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Bisoprolol; Blood Pressure; Cohort Studies; Dose- | 2002 |
[NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cardiac Volume; Heart Failure; Humans; Magnetic Resonance S | 2003 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiac Output; Coronary Angiography; Female; | 2007 |
Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Diuretics; Drug T | 2007 |
Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
Topics: Antihypertensive Agents; Arterioles; Bisoprolol; Blood Pressure; Coronary Circulation; Diastole; Dil | 1998 |
The Cardiac Insufficiency Bisoprolol Study II.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Cerebrovascular Disorders; Humans; Thrombosis; Ventricular | 1999 |